Patent Assignment
Reel/Frame 060643/0035
Assignment of Assignor's Interest
Recorded: 2022-07-27
Pages: 3
Assignor
ERLANSON, DANIEL
Executed: 2011-01-04
Assignee
SUNESIS PHARMACEUTICALS, INC.
395 OYSTER POINT BOULEVARD, SUITE 400, SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Property
(1)
Heterocyclic Compounds Useful as PDK1 Inhibitors
Application:
17/814,224 →
Publication:
US 2023/0113598
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jul 27, 2022
From: BIOGEN IDEC MA INC.
To: MILLENNIUM PHARMACEUTICALS, INC.
Reel/Frame 060643/0038 →
Change of Name
Jul 27, 2022
From: SUNESIS PHARMACEUTICALS, INC.
To: VIRACTA THERAPEUTICS, INC.
Reel/Frame 060982/0866 →
Assignment of Assignor's Interest
Jul 27, 2022
From: ARNDT, JOSEPH; CHAN, TIMOTHY; GUCKIAN, KEVIN; KUMARAVEL, GNANASAMBANDAM
To: BIOGEN IDEC MA INC.
Reel/Frame 061040/0001 →